SOPHiA GENETICS: Menu proposes $181K share sale
The notice also lists six prior sales identified as 10b5-1 sales and says the shares came from vested restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SOPHiA GENETICS SA is the issuer in Officer Philippe Menu’s notice of a proposed sale of 22,394 common shares, with an aggregate market value of $180,719.58 and an approximate sale date of October 5, 2026. The shares were acquired upon vesting of restricted stock units from January 3, 2026 through October 3, 2026. The notice also lists six prior sales identified as 10b5-1 sales, including 5,000 shares on September 14, 2026 and 7,393 shares on July 6, 2026.
Key Figures
Key Terms
restricted stock units financial
10b5-1 Sales regulatory
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.